PAG
ABMD

Private Advisory Group’s Abiomed Inc ABMD Stock Holding History

Private Advisory Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,335
Closed -$370K – 133
2020
Q3 		$370K Buy
+1,335
New +$385K 0.15% 88
2018
Q3 		– Sell
-2,780
Closed -$1.14M – 146
2018
Q2 		$1.14M Buy
+2,780
New +$1.01M 0.57% 58

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Private Advisory Group's ABMD Position: Q4 2020 in Review

Private Advisory Group sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 1,335 shares — an estimated $370K sold.

Private Advisory Group first reported a position in ABMD in Q2 2018 and held it in 2 quarters. The position peaked at $1.14M in Q2 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Private Advisory Group reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Private Advisory Group sold 1,335 Abiomed Inc shares in Q4 2020, an estimated $370K.
  • Private Advisory Group first reported a position in Abiomed Inc in Q2 2018 and held it in 2 quarters.
  • Private Advisory Group's Abiomed Inc position peaked at $1.14M in Q2 2018.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Private Advisory Group's 13F filing for Q4 2020, filed 5 Feb 2021.